Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.680
-0.010 (-0.37%)
At close: Dec 20, 2024, 4:00 PM
2.720
+0.040 (1.49%)
After-hours: Dec 20, 2024, 7:04 PM EST
Nuvation Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -532.28 | -75.8 | -104.2 | -86.85 | -41.66 | -33.55 | |
| Depreciation & Amortization | 0.52 | 0.22 | 0.2 | 0.18 | 0.1 | 0.01 | |
| Loss (Gain) From Sale of Assets | 0.16 | 0.01 | 0.05 | - | - | - | |
| Asset Writedown & Restructuring Costs | 425.07 | - | - | 3.79 | - | 4.75 | |
| Loss (Gain) From Sale of Investments | -10.63 | -11.92 | 4.9 | 4.67 | 0.72 | 0.21 | |
| Stock-Based Compensation | 25.81 | 19.51 | 16.29 | 9.27 | 2.2 | - | |
| Other Operating Activities | -0.58 | -0.56 | -9.9 | -4.05 | - | 2.66 | |
| Change in Accounts Payable | 4.21 | 0.07 | -1.79 | 1.86 | 0.03 | 1.95 | |
| Change in Other Net Operating Assets | -9.44 | 0.47 | -1.66 | 2.93 | 2.08 | -0.46 | |
| Operating Cash Flow | -99.14 | -68 | -96.11 | -68.19 | -36.53 | -24.43 | |
| Capital Expenditures | -0.19 | -0.07 | -0.37 | -0.28 | -0.15 | -0.66 | |
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | - | - | - | |
| Investment in Securities | 91.75 | 8.98 | 63.81 | -454.39 | -70.18 | -115.2 | |
| Investing Cash Flow | 104.09 | 8.92 | 63.46 | -454.67 | -70.32 | -115.86 | |
| Short-Term Debt Issued | - | - | - | - | - | 0.03 | |
| Long-Term Debt Issued | - | - | - | - | - | 14.99 | |
| Total Debt Issued | 7.04 | - | - | - | - | 15.02 | |
| Short-Term Debt Repaid | - | - | - | - | - | -0.63 | |
| Total Debt Repaid | -9.53 | - | - | - | - | -0.63 | |
| Net Debt Issued (Repaid) | -2.5 | - | - | - | - | 14.39 | |
| Issuance of Common Stock | 3.85 | 0.63 | 1.33 | 0.76 | - | 5.01 | |
| Other Financing Activities | - | - | - | 624.77 | -2.52 | - | |
| Financing Cash Flow | 1.35 | 0.63 | 1.33 | 625.53 | 133.14 | 143.62 | |
| Net Cash Flow | 5.64 | -58.45 | -31.32 | 102.67 | 26.29 | 3.33 | |
| Free Cash Flow | -99.33 | -68.07 | -96.48 | -68.47 | -36.67 | -25.09 | |
| Free Cash Flow Per Share | -0.42 | -0.31 | -0.45 | -0.35 | -0.38 | -0.12 | |
| Levered Free Cash Flow | -33.29 | -41.59 | -62.44 | -39.03 | -25.63 | -20.46 | |
| Unlevered Free Cash Flow | -33.13 | -41.59 | -62.44 | -39.03 | -25.63 | -18.8 | |
| Change in Net Working Capital | -24.76 | -1.13 | 3.73 | -7.76 | 0.57 | -1.91 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.